Literature DB >> 16606790

Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model.

Marvin G Chang1, Leslie Tung, Rajesh B Sekar, Connie Y Chang, Josh Cysyk, Peihong Dong, Eduardo Marbán, M Roselle Abraham.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) are bone marrow stromal cells that are in phase 1 clinical studies of cellular cardiomyoplasty. However, the electrophysiological effects of MSC transplantation have not been studied. Although improvement of ventricular function would represent a positive outcome of MSC transplantation, focal application of stem cells has the potential downside of creating inhomogeneities that may predispose the heart to reentrant arrhythmias. In the present study we use an MSC and neonatal rat ventricular myocyte (NRVM) coculture system to investigate potential proarrhythmic consequences of MSC transplantation into the heart. METHODS AND
RESULTS: Human MSCs were cocultured with NRVMs in ratios of 1:99, 1:9, and 1:4 and optically mapped. We found that conduction velocity was decreased in cocultures compared with controls, but action potential duration (APD80) was not affected. Reentrant arrhythmias were induced in 86% of cocultures containing 10% and 20% MSCs (n=36) but not in controls (n=7) or cocultures containing only 1% MSCs (n=4). Immunostaining, Western blot, and dye transfer revealed the presence of functional gap junctions involving MSCs.
CONCLUSIONS: Our results suggest that mixtures of MSCs and NRVMs can produce an arrhythmogenic substrate. The mechanism of reentry is probably increased tissue heterogeneity resulting from electric coupling of inexcitable MSCs with myocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606790     DOI: 10.1161/CIRCULATIONAHA.105.593038

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  85 in total

Review 1.  Protein localization in the plant Golgi apparatus and the trans-Golgi network.

Authors:  C Saint-Jore-Dupas; V Gomord; N Paris
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 2.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

3.  Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells.

Authors:  Gregory W Serrao; Irene C Turnbull; Damian Ancukiewicz; Do Eun Kim; Evan Kao; Timothy J Cashman; Lahouaria Hadri; Roger J Hajjar; Kevin D Costa
Journal:  Tissue Eng Part A       Date:  2012-06-25       Impact factor: 3.845

4.  A device for separated and reversible co-culture of cardiomyocytes.

Authors:  Michael Q Chen; R Hollis Whittington; Peter W Day; Brian K Kobilka; Laurent Giovangrandi; Gregory T A Kovacs
Journal:  Biotechnol Prog       Date:  2010 Jul-Aug

Review 5.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

Review 6.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 7.  Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.

Authors:  Alexander R Lyon; Sian E Harding; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2008-07-16       Impact factor: 4.132

8.  Effect of skeletal muscle Na(+) channel delivered via a cell platform on cardiac conduction and arrhythmia induction.

Authors:  Gerard J J Boink; Jia Lu; Helen E Driessen; Lian Duan; Eugene A Sosunov; Evgeny P Anyukhovsky; Iryna N Shlapakova; David H Lau; Tove S Rosen; Peter Danilo; Zhiheng Jia; Nazira Ozgen; Yevgeniy Bobkov; Yuanjian Guo; Peter R Brink; Yelena Kryukova; Richard B Robinson; Emilia Entcheva; Ira S Cohen; Michael R Rosen
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-21

9.  An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies.

Authors:  Carlos Almeida Ramos; Zahra Asgari; Enli Liu; Eric Yvon; Helen E Heslop; Clio M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

Review 10.  Electrophysiological challenges of cell-based myocardial repair.

Authors:  Huei-Sheng Vincent Chen; Changsung Kim; Mark Mercola
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.